Subscribe to our Private Equity & Business Newsletter

Private Equity 9 2

Tim Schlidt, Principal at Palo Santo on Investing in Companies Researching Psychedelics as Treatments for Mental Health Issues 12-4-20

This episode features Tim Schlidt, Principal at Palo Santo. Here he discusses his background in private equity, how psychedelics have medical potential in treating mental health issues, how therapy with a psychedelic works, the kinds of companies in the Palo Santo portfolio, and more.

Subscribe

Becker Private Equity & Business Podcast

Becker Business Minute Podcast

To suggest a webinar or podcast guest, please contact sbecker@beckerstrategygroup.com